Clinical Trials Browser

Phase 2 × Lymphoma, Follicular × parsaclisib × Clear all

NCT03126019 2025-03-14

CITADEL-203

Phase 2 Completed

126 enrolled 15 charts

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Hereditary Sensory and Autonomic Neuropathies

NCT04434937 2024-10-23

Open-Label Study of Parsaclisib, in Japanese Participants With Relapsed or Refractory Follicular Lymphoma (CITADEL-213)

Phase 2 Completed

42 enrolled 13 charts

Lymphoma, Lymphoma, Follicular

NCT04298879 2024-06-05

IBI376 in Patients With Relapsed or Refractory Follicular Lymphoma/Marginal Zone Lymphoma

Phase 2 Completed

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone